(Q40006167)

16 September 2017

title

Niacin inhibits surface expression of ATP synthase beta chain in HepG2 cells: implications for raising HDL. (English)

1 reference

16 September 2017

1 reference

ChEBI release 2020-05-28

Lin-Hua Zhang

1

1 reference

16 September 2017

Vaijinath S Kamanna

series ordinal

2

1 reference

16 September 2017

Michael C Zhang

series ordinal

3

1 reference

16 September 2017

Moti L Kashyap

series ordinal

4

1 reference

16 September 2017

publication date

3 March 2008

1 reference

Journal of Lipid Research

16 September 2017

published in

1 reference

16 September 2017

volume

49

1 reference

16 September 2017

issue

6

1 reference

16 September 2017

page(s)

1195-1201

1 reference

High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies

16 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M700426-JLR200

HDL and arteriosclerosis: beyond reverse cholesterol transport

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M700426-JLR200

Niacin therapy in atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M700426-JLR200

Effects of Nicotinic Acid Therapy on Plasma High Density Lipoprotein Subfraction Distribution and Composition and on Apolipoprotein A Metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M700426-JLR200

Niacin, but not gemfibrozil, selectively increases LP-AI, a cardioprotective subfraction of HDL, in patients with low HDL cholesterol

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M700426-JLR200

Identification of scavenger receptor SR-BI as a high density lipoprotein receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M700426-JLR200

A docking receptor for HDL cholesterol esters

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M700426-JLR200

Ectopic beta-chain of ATP synthase is an apolipoprotein A-I receptor in hepatic HDL endocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M700426-JLR200

Molecular architecture of the rotary motor in ATP synthase

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M700426-JLR200

Ecto-F1Fo ATP synthase/F1 ATPase: metabolic and immunological functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M700426-JLR200

Cell surface adenylate kinase activity regulates the F(1)-ATPase/P2Y (13)-mediated HDL endocytosis pathway on human hepatocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M700426-JLR200

Cell surface F1Fo ATP synthase: a new paradigm?

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M700426-JLR200

Interaction of the C-terminal domain of p43 and the alpha subunit of ATP synthase. Its functional implication in endothelial cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M700426-JLR200

Intracellular signaling for vasoconstrictor coupling factor 6: novel function of beta-subunit of ATP synthase as receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M700426-JLR200

Cholesterol loading increases the translocation of ATP synthase beta chain into membrane caveolae in vascular endothelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M700426-JLR200

Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M700426-JLR200

Effects of torcetrapib in patients at high risk for coronary events

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M700426-JLR200

10.1194/JLR.M700426-JLR200

21 January 2018

Identifiers

DOI

1 reference

16 September 2017

1 reference